Affordable Access

Publisher Website

Faecal calprotectin concentrations and diagnosis of necrotising enterocolitis

Authors
Journal
The Lancet
0140-6736
Publisher
Elsevier
Publication Date
Volume
361
Issue
9354
Identifiers
DOI: 10.1016/s0140-6736(03)12333-1
Keywords
  • Primary Research
  • Research Letters
Disciplines
  • Medicine

Abstract

Summary Calprotectin has been proposed as a useful marker of inflammatory bowel disease in children. We did a pilot study to establish whether it can be used to aid diagnosis of necrotising enterocolitis in preterm infants. Patients with clinical features of necrotising enterocolitis had raised faecal calprotectin concentrations at the time of diagnosis compared with matched controls (288·4 mg/L [SD 49·1] and 98·0 mg/L [60·6], respectively; p=0·0006). Faecal calprotectin might be a useful marker of gastrointestinal mucosal inflammation in neonates.

There are no comments yet on this publication. Be the first to share your thoughts.